Lipidized tumors of the central nervous system are very uncommon, with only a few cases described. We report a case of a 25-year-old woman with a tumor involving the left premotor area. She underwent gross total excision. Histologically, the tumor was composed of glial fibrillary acidic protein-positive glial cells with areas of lipidization. A diagnosis of lipoastrocytoma was rendered. At three-year follow-up she was doing well, supporting the presumed favorable prognosis of these uncommon tumors. Absence of xanthochromic appearance, mitotic activity, necrosis and poor reticulin activity are the differentiating features from the pleomorphic xanthoastrocytoma. We highlighted that these tumors involve the adult and pediatric population and distribute in both supratentorial and infratentorial compartments as well as in the spinal cord.
Introduction
Lipidization is a rare but well-described finding in a variety of neuroectodermal tumors of the central nervous system (CNS). 1 Lipidization of tumor cells has been reported in a few primary neuroepithelial tumors. Fat globules may accumulate within the cytoplasm of tumor cells as multiple droplets, giving a xanthomatous appearance. This was documented in tumors like pleomorphic xanthoastrocytoma (PXA) 2, 3 and glioblastoma. 4 This is quite different from lipomatous tumor cells that have fat droplets coalescing into a single clear vacuole that displaces the nucleus to the cytoplasmic margin, resembling a mature adipocyte. This has been observed in ependymomas, 5 central liponeurocytomas, 6 cerebellar liponeurocytomas, 7 and in the low-grade lipoastrocytoma without a neural component. 8, 9 We report the case of a low-grade astrocytoma with plentiful lipomatous components.
Case report
A 24-year-old female patient presented with complaints of headache and right-sided focal motor seizures with secondary generalization for two months. She did not have any neurological deficits. Magnetic resonance imaging (MRI) showed a 38 Â 29 Â 26 mm intra-axial tumor involving the left frontal region in front of the precentral gyrus with significant perilesional edema involving the left frontal and parietal lobes. It was iso-to hypointense on T1-weighted images (T1WI), hyperintense on T2-weighted and fluid-attenuated inversion recovery (FLAIR) images and showed heterogeneous contrast enhancement. The peripheral part of the tumor showed restricted diffusion. There was no blooming seen on susceptibility images. Spectroscopy was non-contributory ( Figure 1(a)-(h) ). We considered high-grade glioma and metastasis as differential diagnoses in view of the contrast enhancement pattern and edema. We also considered tuberculoma as one of the differentials because of heterogenous enhancement with central non-enhancing areas with disproportionate edema surrounding the lesion. She underwent a left frontoparietal craniotomy and tumor excision. On opening of the dura, the intra-axial tumor was seen surfacing; it was reddish gray, soft, suckable and moderately vascular. In the gross appearance we could not find a yellowish tinge imparted because of fat. Our intraoperative impression was high-grade glioma or glioblastoma. Gross total excision was performed, which was confirmed in the postoperative computed tomography (CT) (Figure 2(a) ). In the immediate postoperative period, the patient developed right upper limb paresis that improved during the hospital stay. Histopathology examination showed predominantly spindle-shaped cells arranged in fascicles with vesicular nuclei. Cytoplasmic projections were seen in many cells along with focal dystrophic calcification. Increased vascularity with focal perivascular arrangement of tumor cells was noted. There was an increase in thin, small, single-layered endothelial lining vasculature. There were no features of microvascular proliferation or hyalinization of vessels seen. Nuclei were ovoid with mild atypia. In addition, prominent lipomatous differentiation along with numerous eosinophilic granular bodies were seen. There were several large clear cells (adipocytes) admixed within the glial cells. There was no mitosis, microvascular proliferation or necrosis. Immunohistochemistry for glial fibrillary acidic protein (GFAP) and S-100 protein was positive in tumor cells; it was negative for epithelial membrane antigen, synaptophysin and poor in reticulin. Ki-67 (MIB-1) labeling index was <1% (Figure 3 
Discussion
Lipidization occurs uncommonly in primary neuroepithelial neoplasms of the CNS. Lipidization predominantly presents in two patterns. It may present as multiple droplets of fat within the cytoplasm of tumor cells without any clumping, giving rise to a xanthomatous appearance. The second phenomenon is coalescence of these different lipid droplets into a single large droplet, resulting in an adipocyte-like cell appearance. 8, 9 This kind of lipomatous transformation of neoplastic cells has been reported in cerebellar liponeurocytoma and a few cases of ependymoma, central neurocytoma, primitive neuroectodermal tumor and lipoastrocytoma. [8] [9] [10] A lipidized stage has been described in the normal development stages of the nervous system and myelinization of the white matter as well. 11, 12 Because the lipid-loaded cells retain the immunophenotype of the non-lipidized tumor cells, i.e. GFAP positivity, and display glial nature, a degenerative/metabolic change rather than metaplasia or differentiation has been contemplated. This could represent involutional change. 9, 11, 12 The vacuolar lipid accumulation is the pathognomic feature of lipoastrocytoma. 13 The present case showed increased vascularity with focal perivascular arrangement akin to cellular ependymoma. It was described by a few authors and was seen in our case as well. 12, 14, 17 However, lack of a true ependymal rosette, alternating hypocellular and cellular areas and presence of eosinophilic granular bodies ruled out the possibility of ependymoma. Glioblastoma show mitotic activity with microvascular proliferation, necrosis and a high MIB-1 labeling index, which was lacking in the present case. Absence of neuropil-like areas and neuronal differentiation on morphology and immunohistochemistry ruled out liponeurocytoma. The detection of cytoplasmic GFAP in astrocytes helps in recognition of the glial nature of this neoplasm, especially if the cells are densely lipidized. 12, 14 To date, 13 case reports of lipoastrocytoma are available (Table 1) . Eleven cases have been reported in the English literature 8, 9, [11] [12] [13] [14] [15] [17] [18] [19] and one each in the Spanish 16 and Chinese literature. 20 There was an almost equal sex distribution with seven male and six female patients. The ages varied from 2 to 77 years. Nine patients were above 18 years, showing an adult dominance. Two cases were reported in the spine, four cases in the posterior fossa and eight in the supratentorial compartment. This shows that lipoastrocytomas have more or less equal predilection to occur in all regions of the CNS, unlike other neuroectodermal tumors with lipidization like PXA and cerebellar liponeurocytoma. 13 Craver et al. reported a case of lipoastrocytoma following radiation therapy. 19 Massimi et al. reported a mild increase in size of tumor following radiation therapy given for a posterior fossa tumor in the same patient. 18 PXAs are reported to occur most often in supratentorial compartment in children and adolescents. They are superficially located tumors with attachment to meninges and morphologically different from lipoastrocytoma as the former show cellular pleomorphism, with spindle and tumor giant cells having multiple cytoplasmic vacuoles giving the cytoplasm a xanthomatous appearance. 21, 22 In addition mature ganglion cells, lymphocytic infiltrate and eosinophilic granular bodies are also seen. This is one of the glioma that is reticulin rich unlike lipoastrocytoma (present case was reticulin poor). PXA can show features of high grade and depending on histological features PXA is divided into typical, proliferating and malignant. 23 Histologically, the hallmark feature of all these tumors is the glial cells containing fat droplets coalescing into one large droplet. GFAP positivity of tumor by immunohistochemistry clinches the diagnosis. Many reported cases showed negative staining to actin, synaptophysin and neurofilaments. Rosenthal fibers have been reported rarely. Mitotic activity, vascular proliferation and necrosis seen in PXA are usually not seen in lipoastrocytoma. 8 Pseudorosettes have been documented by a few authors. 12, 17 Molecular analyses performed on lipoastrocytoma by Giangaspero et al. did not show any typical genetic alterations. 8 CT and MR features were also not uniform enough in the reported cases to characterize the tumor. 9, 11, 12, 14, 17, 18, 20 The current treatment of these tumors is maximum safe resection. The benefit of adjuvant therapies like radiotherapy or chemotherapy is controversial and there is no evidence of long-term benefit. 11, 12 Resection is also recommended for recurrences or regrowth of residual disease. 11, 12 In view of the low MIB-1 index, lipoastrocytoma is considered to have an indolent course. 8, 11, 18 The longterm prognosis of lipoastrocytoma is unknown because of the limited number of cases and short follow-up periods reported in them. Two cases with five and seven years follow-up point to a favorable prognosis. 8 In the case reported by Massimi et al., it was reported that the tumor did not disappear completely after radiotherapy and chemotherapy. 18 Like many authors have suggested, 9, 11, 12 it may be worth documenting each new case to produce a better characterization of this uncommon tumor and its biologic behavior. We attempted to explain the detailed morphological and histological features along with distribution of this uncommon tumor among different sex and age groups and its location in the CNS.
Conclusions
Lipoastrocytoma is an uncommon neoplasm occurring equally in both sexes and affecting the pediatric and adult population. The present case emphasizes the histological diagnosis. Gross total excision is the recommended treatment. Although many authors do not advocate adjuvant therapy, it requires long-term follow-up.
